AZD9550 + lenbelintide
AZD9550 + AZD6234 · AstraZeneca
Amylin plus GLP-1/glucagon co-administration; its own Phase 2 program.
Results availability
No numerical study results are currently summarized for this profile. The development stage and linked studies are listed below.
Mechanism at a glance
Obesity stage by formulation
Latest: The Phase 2 ASCEND obesity study is completed; results are pending.
Next: Phase 2b efficacy and safety results.
Clinical study records
Obesity and weight-management studies appear first. Related-condition trials follow by phase, with focus labels to show what each study evaluates. Study stage and results reporting are listed separately. Results summarized above are identified as peer-reviewed or sponsor reported. Otherwise, the label states whether results were posted to a registry or reported in the linked source.
Obesity and weight-management studies
Phase 2 studies1 record
ASCEND · AZD9550 + lenbelintide
Weight managementObesity/overweight with a complication; combination versus components and placebo.
